MarketInOut Stock Screener Log In | Sign Up
 

Corbus Pharmaceuticals Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026 16:00
Corbus Pharmaceuticals Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization82.88 mln
Float17.36 mln
Earnings Date11/10/2026

Piotroski F-Score

1 / 9
Very weak

Relative Strength

9 / 100
Severely lagging

Debt / Equity

0.04
Debt-free

ROE

-87.97
Deeply negative

ROA

-75.57
Deeply negative

Business Description

Corbus Pharmaceuticals is a clinical-stage company based in Norwood, Massachusetts, focused on developing new treatments for cancer and obesity. Its two lead programs include an antibody-based therapy designed to target and destroy cancer cells, and a weight-loss drug candidate engineered to reduce appetite without affecting the brain. Founded in 2009, the company is working to advance both treatments through clinical development.

Key Fundamentals

EPS-6.11
ROE-87.97
ROIC-1,890
ROA-75.57
EBITDA, mln-102
EV / EBITDA-0.25
EV / EBIT-0.25

Quote Details

Last 4.05
Change -0.08 (-1.94%)
Open 4.08
Volume 372,430
Turnover 1,508,342
Average Volume 849,341

Financial Ratios

Leverage Ratio1.24
Current Ratio5.71
Price / Book1.24
Price / Tangible Book1.24
Debt / Equity0.04

Financial Strength

Piotroski F-Score 1 / 9
Short Ratio2.35
Short % of Float18.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.4% 8 / 100   
1 Month -45.64% 5 / 100   
2 Months -54.44% 7 / 100   
6 Months -59.74% 9 / 100   
1 Year -77.17% 9 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog